Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT02791854

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

Innovative programs exist that suggest that care for people with chronic conditions is optimized when patients and providers have the information they need at the point of care and over time, to engage in shared planning and execution of treatment goals and care plans. This project aims to build an Inflammatory Bowel Disease Learning Health System, a shared information environment, that highlights collaboration among patients, clinicians and care team members, and researchers; for effective use of data for guiding care, value, improvement, and research.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Cedars-Sinai Inflammatory Bowel Disease Center, Los Angeles, California, United States

Loading trial locations.

About this study

To demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) Learning Health System approach the study collaborators will design, build, implement, and evaluate in up to 90 IBD care sites the the following four key components of the IBD Learning Health System: 1) a Health Information Technology (HIT) environment that can "feed-forward" Patient Reported Outcomes (PROs) and clinical data to be used at the point of care and integrated into a registry (IBD Plexus); 2) decision-support dashboards for use by patients and clinicians in real time to coproduce care; 3) meaningful reports for patients and clinicians; and 4) multi-stakeholder collaborative networks for improvement and research.

Prior work from Sweden and the US show that successful uptake of the model can offer important benefits. Patients will be able to use web-based tools to monitor their health and manage their care, securely share data with clinicians in a timely manner, visualize outcomes that matter to them, and compare their results to other people. Clinicians will have new information that can improve their ability to track patient outcomes and costs over time; use PRO data to support pre-visit planning, shared decision-making at the point of care, and post-visit monitoring; and receive comparative performance reports to support quality improvement, public reporting, and professional development. Researchers will benefit by having PROs and cost data added to data registries to support clinical, translational, and comparative effectiveness research.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified
  • Accept the terms and conditions of Informed Consent and Authorization
  • Affiliated with a participating IBD Qorus site

Exclusion criteria

  • Inability to provide informed consent
  • Study key personnel cannot enroll as a study participant

Treatment and study plan

Primary outcomes

  1. Number of patients enrolled

    Time frame: annually, up to 5 years

    count of number of patients consented

Secondary outcomes

  1. Proportion of patients in remission

    Time frame: annually, up to 5 years

    assessed using a validated disease activity scale

  2. Proportion of patients on steroids

    Time frame: annually, up to 5 years

    assessed by patient report

  3. Proportion of patients admitted into the Emergency Room

    Time frame: annually, up to 5 years

    assessed by patient report

  4. Proportion of patients hospitalized

    Time frame: annually, up to 5 years

    assessed by patient report

  5. Proportion of patients with anemia

    Time frame: annually, up to 5 years

    assessed by patient report and labs

  6. Proportion of patients with malnutrition

    Time frame: annually, up to 5 years

    assessed by patient report and labs

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Collaborators

  • Cedars-Sinai Medical Center
  • Crohn's and Colitis Foundation
  • Dartmouth College

Registry information

Acronym: IBD:QORUS

Important dates

Study start
2016
Primary completion
2030
Study completion
2030
First posted
Jun 7, 2016
Registry last updated
Aug 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.